Eight GLP-1 telehealth providers deliver compounded semaglutide and tirzepatide with no separate membership fee. Month-to-month pricing varies from $129 to $349, and cancellation policies differ. This comparison uses checkout-verified rates captured through September 2026.

We compared all-in pricing for compounded semaglutide across twelve telehealth providers. Several advertise first-month discounts; refill rates, membership fees, and route availability reshape the 12-month cost.

Remedy Meds publishes no product prices until after intake, but verified evidence shows $189/month microdose and $299–$399/month standard-dose figures. We compare those rates against PlexusDx's published ladder.

Remedy Meds advertises "$9.99 per day" but does not disclose which medication or dose that rate applies to until after intake. This breakdown shows the actual monthly costs, what's included, and how Remedy compares to transparent pricing alternatives.

Zealthy advertises compounded semaglutide at $151/month when billed quarterly and branded GLP-1s from $25/month with insurance. We document what's disclosed, what requires checkout, and where evidence gaps prevent a full cost comparison.

Zealthy advertises compounded semaglutide at $151/month, but this figure is a quarterly prepaid equivalent with undisclosed upfront totals and membership fees. The month-to-month rate is not published.

PlushCare charges $19.99/month membership after 30 days free, plus $129 initial visit. Medication and labs are extra, paid at an external pharmacy. Total monthly cost depends on pharmacy pricing and insurance coverage, which PlushCare does not disclose.

Found advertises monthly rates as low as $99, but that figure requires insurance coverage and paying $1,188 upfront for twelve months. This breakdown explains Found's two-track pricing, medication inclusion, copay layer, and how prepayment works.

Found's cash-pay program offers semaglutide at $289 monthly or $169 per month with a $2,028 annual prepay, while PlexusDx charges $189 month-to-month. How the costs compare depends on commitment and billing cadence.

Found offers two pricing models—insurance-supported plans and cash-pay subscriptions—with rates ranging from a 12-month prepaid equivalent of $99/month to $359/month billed monthly. We break down each track's real recurring costs, medication coverage, and what the insurance option actually covers.

10Rx charges $450 every three months for compounded tirzepatide injection—$150 per month when prepaid quarterly. We compare that upfront commitment model against month-to-month pricing and show the true 12-month cost.

AltRx advertises a $900 annual semaglutide plan through September 5, 2026. We document the prepayment structure, per-month rates, and a cancellation-terms conflict reported on Trustpilot.

AltRx is running a promotional tirzepatide campaign through September 5, 2026, with rates from $149 per month on a month-to-month basis down to $125 per month prepaid annually. We compare the promotional structure against standard plans and examine what happens when the promotion ends.

AltRx advertises compounded semaglutide at $89 per month billed monthly, or $75 per month equivalent when you prepay $900 for a 12-month supply. We compare the four plan tiers, calculate 12-month costs, and review checkout considerations.

AltRx advertises compounded semaglutide from $75/month and tirzepatide from $125/month under a promotional rate ending September 5, 2026. Standard post-promotion pricing is not yet verified.

BrightMeds' three-month prepaid GLP-1 plan charges $297 upfront for semaglutide ($99/month prepaid rate) or $357 for tirzepatide ($119/month prepaid rate), marketed as a state-limited summer promotion. Standard month-to-month rates are $129 and $149 respectively.

BrightMeds tirzepatide costs $149/month on its standard plan or a prepaid rate of $357 per quarter ($119/month equivalent), versus PlexusDx at $289 month-to-month. We compare both billing models, promotional limits, and what the difference means over 12 months.

MEDVi offers branded Wegovy and Zepbound through a membership-plus-medication model: a flat membership fee, with the medication billed separately and its price not published. This guide explains what the membership covers, how to build a two-line total, how it differs from MEDVi's compounded program, and how PlexusDx's compounded pathway compares.

Advertised GLP-1 telehealth rates often exclude membership fees, dose escalation surcharges, and upfront commitments. This comparison normalizes per-month costs across ten providers to reveal true recurring expense.

BrightMeds lists semaglutide at $129 month-to-month and $99/month prepaid equivalent for a 3-month plan, both lower than PlexusDx's $189 month-to-month and $169 3-month rates. We compare the two programs on cost, plan structure, and evidence quality.

MEDVi lists a daily compounded semaglutide tablet priced about $70 a month over its injection rate, with no tablet total published on its public page. This guide explains what is published for the oral plan, compares tablet to tablet and tablet to injection on the same terms, and sets out the questions to ask before choosing a route.

MEDVi advertises one price for a new patient's first month and a different, higher price for refills. This guide explains why the two figures are separate fields, which products publish each figure, how to total a multi-cycle course honestly, and which questions to ask before enrolling.

Found charges no separate membership fee—clinician access, app tools, and support are included in medication cost. PlexusDx follows the same model. The decision hinges on cash affordability versus insurance coverage and bundled features.

MEDVi prices its compounded programs with a lower first payment for new patients, then a locked refill rate for every later billing cycle. This guide explains MEDVi's verified tirzepatide refill rate, the one figure you must still confirm in its official offer (the first-month offer), how the first three cycles add up, and how PlexusDx month-to-month and commitment tiers compare.

Several compounded GLP-1 programs deliver semaglutide or tirzepatide for less than $150 per month—if you qualify for their starting doses, prepay multi-month plans, or accept microdose formulations.

Sixteen telehealth providers now offer flat-rate compounded semaglutide with no dose-based upcharges. This comparison maps month-to-month and prepaid pricing, membership structures, and twelve-month costs across all major platforms.

Eight telehealth providers hold tirzepatide prices constant from starter dose through maintenance. We compare their rates, membership fees, and prepay requirements to show the true monthly cost when your dose scales up.

If you're moving from another GLP-1 provider, Found offers insurance-accepted options and a cancellation-friendly structure. PlexusDx delivers lower cash prices, oral formats, and month-to-month flexibility. Here's how the economics and features compare for transfer patients.

We reviewed 50 GLP-1 telehealth providers and evaluated pricing structure, medication access, membership requirements, and service quality across every major platform in 2026.

Zealthy advertises compounded semaglutide from $151 monthly when paid quarterly, but the upfront total and membership fees remain undisclosed on public pages. PlexusDx lists transparent month-to-month and prepaid rates with no hidden membership.